oVio Technologies Inc

 oVio Technologies has built a patented, AI-powered 360° dimensional imaging platform capturing underserved opportunities across two high-growth verticals. In melanoma screening, AI-assisted detection is reported up to 10x more accurate than the human eye — developed with MIT and validated by Johns Hopkins. Markets served include principal care providers, hospitals, med spas, wellness centers, and dermatologists. In AI-driven identity management, continuously-learning recognition technology has potential deployments with the various state Departments of Corrections, TSA, the U.S. Air Force, the State Department, and other state and federal agencies.